Form 8.3 - Allergan plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

29th April 2020

  1. INTERESTS AND SHORT POSITIONS
  1. Interests and short positions (following dealing) in the class ofrelevant security dealt in(Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,363,079

(1.325%)

 

2,672

(0.001%)

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

-

-

Total

4,363,079

(1.325%)

 

2,672

(0.001%)

 
  1. Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

  1. DEALINGS (Note 4)
  1. Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

(USD)

Sale

3,804

189.29

Purchase

749

189.12

Purchase

1

189.11

Purchase

215

189.20

Purchase

220

189.10

Purchase

804

189.15

Purchase

666

189.05

Purchase

300

189.21

Purchase

420

188.97

Purchase

1

189.01

Purchase

473

189.03

Purchase

1

189.16

Purchase

234

188.94

Sale

119

189.35

Purchase

50

189.18

Sale

396

187.72

Sale

34

187.72

Sale

100

188.16

Sale

133

187.18

Sale

10

188.01

Purchase

282

189.21

Sale

100

187.51

Purchase

82

189.59

Sale

70

188.45

Sale

200

187.78

Purchase

1,730

188.91

Purchase

46

189.16

Purchase

10

188.79

Purchase

349

189.64

Sale

100

187.36

Purchase

303

189.60

Purchase

133

189.91

Purchase

437

188.72

Purchase

31

189.56

Sale

10,819

189.29

Purchase

2,336

189.48

Sale

203

187.72

Purchase

203

189.29

Purchase

35

187.46

Sale

6

189.12

Sale

7

189.10

Purchase

100

189.21

Sale

6

189.01

Sale

35

187.73

Purchase

2,465

189.52

Purchase

1,416

189.59

Sale

26

189.59

Purchase

995

189.58

Purchase

635

189.73

Purchase

1,300

189.62

Sale

25

189.62

Purchase

1,733

189.68

Purchase

1,300

189.78

Purchase

315

189.71

Purchase

1,700

189.79

Purchase

800

189.77

Purchase

70

187.45

Purchase

1,951

189.69

Purchase

2,160

189.66

Purchase

567

189.85

Purchase

700

189.64

Sale

5

188.99

Purchase

459

189.82

Purchase

1,300

189.65

Sale

4

189.65

Purchase

514

189.93

Purchase

800

189.60

Purchase

517

189.92

Purchase

400

189.89

Purchase

193

189.87

Purchase

898

189.91

Purchase

307

189.88

Purchase

200

189.63

Sale

527

189.63

Purchase

200

189.83

Purchase

650

189.72

Sale

12

188.90

Purchase

100

189.84

Purchase

1,100

189.57

Purchase

1,200

189.70

Purchase

200

189.76

Purchase

1,400

189.67

Purchase

906

189.56

Purchase

300

189.94

Purchase

600

189.80

Purchase

500

189.49

Purchase

400

189.74

Purchase

701

189.50

Purchase

4,869

189.29

Purchase

216

189.75

Purchase

600

189.51

Purchase

400

189.61

Purchase

395

189.54

Sale

57

189.54

Purchase

4

189.86

Purchase

200

189.90

Sale

6

189.27

Purchase

627

189.53

Purchase

100

189.47

Sale

100

189.28

  1. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

  1. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

 


 

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

30th April 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

Short Name: MILLENNIUM PARTNERS, L.P.
Category Code: RET
Sequence Number: 698597
Time of Receipt (offset from UTC): 20200430T120750+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.